Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.543, 2007-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Will patents hinder the progress made in HIV treatment?
Inpharma, Vol. 1, Iss. 1503, 2005-01 ,pp. :
Enfuvirtide: a new revolu-T20n in HIV treatment?
Inpharma, Vol. 1, Iss. 1353, 2002-01 ,pp. :
Dopamine Agonists in Parkinsons Disease: What is Their Role in Early Treatment?
By Stocchi F.
CNS Drugs, Vol. 10, Iss. 3, 1998-09 ,pp. :
Muscarinic Receptor Agonists in Alzheimer's Disease: More Than Just Symptomatic Treatment?
By Fisher A.
CNS Drugs, Vol. 12, Iss. 3, 1999-09 ,pp. :
Is it worth increasing dose-density in cancer treatment?
Inpharma, Vol. 1, Iss. 1246, 2000-01 ,pp. :